Renaissance Technologies’s Enveric Biosciences ENVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.8K | Buy |
+37,012
| New | +$44.8K | ﹤0.01% | 3409 |
|
|
2023
Q3 | – | Sell |
-1,145
| Closed | -$58K | – | 3769 |
|
|
2023
Q2 | $58K | Buy |
+1,145
| New | +$58K | ﹤0.01% | 3586 |
|
|
2022
Q3 | – | Sell |
-1,456
| Closed | -$234K | – | 4102 |
|
|
2022
Q2 | $234K | Sell |
1,456
-1,198
| -45% | -$193K | ﹤0.01% | 3578 |
|
|
2022
Q1 | $657K | Buy |
2,654
+1,915
| +259% | +$474K | ﹤0.01% | 3008 |
|
|
2021
Q4 | $515K | Buy |
739
+82
| +12% | +$57.1K | ﹤0.01% | 3060 |
|
|
2021
Q3 | $1.02M | Buy |
+657
| New | +$1.02M | ﹤0.01% | 2534 |
|
|
2019
Q3 | – | Sell |
-2
| Closed | -$56K | – | 3487 |
|
|
2019
Q2 | $56K | Buy |
+2
| New | +$56K | ﹤0.01% | 3444 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | -$12K | – | 3502 |
|
|
2018
Q4 | $12K | Buy |
+1
| New | +$12K | ﹤0.01% | 3332 |
|